Annual report pursuant to Section 13 and 15(d)

Balance Sheet

v3.20.1
Balance Sheet - USD ($)
Dec. 31, 2019
Dec. 31, 2018
Current assets:    
Cash and cash equivalents $ 13,213,929 $ 6,892,772
Deferred offering cost 10,335 344,936
Other current assets 5,376 14,516
Total current assets 13,229,640 7,252,224
Other non-current assets 122,381 65,731
Total assets 13,352,021 7,317,955
Current liabilities:    
Accounts payable and accrued expenses 724,165 399,551
Total current liabilities 724,165 399,551
Total liabilities 724,165 399,551
Commitments and contingencies (Note 9)
Stockholders' equity:    
Common stock, par value of $0.001 per share, 40,000,000 authorized, 10,587,632 and 9,291,421 shares issued and outstanding at December 31, 2019 and December 31, 2018, respectively 10,587 9,291
Additional paid-in capital 38,508,825 28,567,221
Accumulated other comprehensive loss (10,970) (2,396)
Accumulated deficit (25,880,586) (21,655,712)
Total stockholders' equity 12,627,856 6,918,404
Total liabilities and stockholders' equity $ 13,352,021 $ 7,317,955